Latest Articles

Publication Date
KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer - Targeted Oncology

KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer Targeted Oncology

Published: Jan. 5, 2024, 8 a.m.
A clearer view on ovarian clear cell carcinoma.

Ovarian clear cell carcinoma (OCCC) is a less common subtype accounting for approximately 5% of all epithelial ovarian cancers (EOCs). Clinical experience and research findings confirm the remarkable differences in …

Published: Aug. 17, 2021, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!